Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Shareholder vote
confidence 98%
filed 2026-06-22
Item 5.07
This 8-K Item 5.07 discloses the final voting results from Crinetics Pharmaceuticals' annual stockholder meeting held June 18, 2026, covering three proposals: election of three Class II directors, ratification of PricewaterhouseCoopers LLP as independent auditor, and advisory approval of named executive officer compensation. The filing presents complete vote tallies (For, Against/Withheld, Abstentions, and Broker Non-Votes) for each proposal, which is the core disclosure required under Item 5.07 for shareholder vote results.
View raw filing on EDGAR →
8-K
Governance Other
confidence 75%
filed 2026-06-22
Item 8.01
YHN Acquisition I Limited, a SPAC, deposited $150,000 into its trust account to extend the business combination deadline from June 19, 2026 to September 19, 2026. This is a governance and structural matter related to the SPAC's timeline and trust account management. While material to shareholders as it affects the window for completing a business combination, it does not fit neatly into specific event categories like M&A activity (no combination announced or completed) or other named types, making governance_other the most appropriate classification.
View raw filing on EDGAR →
8-K
Restatement
confidence 98%
filed 2026-06-22
Item 4.02
The filing explicitly discloses non-reliance on previously issued unaudited interim financial statements for the quarters ended August 31, 2024 and November 30, 2024, due to the failure to reflect 50,850,000 shares issued on June 5, 2024 and related stock-based compensation under ASC 718. The Company is restating these financial statements via amended 10-Q/A filings. This is a classic restatement disclosure under Item 4.02, driven by accounting errors in share issuance and stock-based compensation recognition.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-22
Item 5.07
This Item 5.07 disclosure reports the results of Inseego Corp.'s June 16, 2026 annual stockholder meeting, including voting outcomes for three proposals: election of two directors (James B. Avery and Jeffrey Tuder), ratification of CBIZ CPAs P.C. as independent auditors, and an advisory vote on executive compensation. The filing presents vote tallies (For, Against, Abstentions, Broker Non-Votes) for each proposal, which is the core content of a shareholder vote results disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-22
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Delta Air Lines' 2026 Annual Meeting of Shareholders held on June 18, 2026. The filing presents voting results for five proposals: election of fourteen directors, advisory vote on executive compensation, ratification of Ernst & Young LLP as independent auditors, and two shareholder proposals (written consent and cumulative voting). The detailed vote tallies for each matter are the core content of the disclosure, making this unambiguously a shareholder vote results event.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-06-22
Item 2.02
Tianci International announced financial results for the fiscal quarter ended April 30, 2026, via press release filed as Exhibit 99.1. The company reported 121% quarter-to-quarter revenue growth, a swing from a net loss of $959,409 in the prior-year quarter to net income of $91,545, and expansion into mineral ore trading.
View raw filing on EDGAR →
8-K
Auditor Change
confidence 98%
filed 2026-06-22
Item 4.01
The Company dismissed Fruci & Associates II, PLLC as its independent registered public accounting firm on June 17, 2026, and appointed Grassi & Co., CPAs, P.C. as the new auditor on the same date. No disagreements, adverse opinions, or reportable events were noted in connection with the transition.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-22
Item 5.07
The majority stockholder (Hawkeye Holdco, LLC, holding 90.1% of voting power) approved by written consent multiple fundamental corporate actions: a name change to Hawkeye Digital, Inc., an increase in authorized shares from 450 million to 10.05 billion, a reclassification of the Board into three classes, authorization for a reverse stock split (1-for-2 to 1-for-20), and adoption of an Equity Incentive Plan. These structural changes materially affect the company's capital structure and governance.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 92%
filed 2026-06-22
Item 5.02
Stockholders approved the Hawkeye Digital, Inc. 2026 Equity Incentive Plan, a compensatory arrangement designed to provide equity incentives to employees, consultants, and directors.
View raw filing on EDGAR →
8-K
Operational Other
confidence 85%
filed 2026-06-22
Item 8.01
Praxis announced FDA Breakthrough Therapy Designation for elsunersen (PRAX-222) for SCN2A-DEE, supported by positive Phase 1/2 trial results. This is a material regulatory milestone that accelerates development and review timelines for a lead candidate, directly affecting the company's clinical and commercial prospects. While not fitting a specific named category, this is clearly an operational/strategic event material to investors assessing the registrant's pipeline progress.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-22
Item 3.02
This Item 3.02 disclosure describes an unregistered private placement of preferred stock under Regulation D Rule 506(b) to accredited investors. The Company issued 208,797 shares of Series 2025 Preferred Stock during the period June 3–21, 2026, raising approximately $2.08 million in aggregate proceeds. As of the filing date, 11.9 million shares of this series were outstanding, indicating a substantial ongoing capital raise. This is a classic dilutive equity issuance material to investors assessing the registrant's capital structure and ownership dilution.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-06-22
Item 7.01
The filing discloses a declaration of distributions to stockholders across five classes of common stock (Class T, S, D, I, and N), with specific per-share amounts and payment details. This is a routine but material dividend distribution event typical of REITs, which are required to distribute substantially all taxable income to shareholders. The disclosure includes gross distributions, fee deductions, net distributions per share, record date, and payment date information.
View raw filing on EDGAR →
6-K
Earnings release
confidence 75%
filed 2026-06-22
EX-99.1
This press release discloses unaudited operating revenue figures for a newly launched business segment (Smart Campus Services): approximately US$9.49 million cumulative revenue since September 2025 launch through May 31, 2026, with US$3.83 million in April–May 2026 alone. Although the figures are explicitly unaudited and not prepared under U.S. GAAP, the disclosure of material revenue metrics for a significant new business line constitutes a substantive financial announcement that would affect a reasonable investor's assessment of the company's growth trajectory and business diversification. The CEO's statement emphasizing this as "one of the operating businesses that we believe can define the Company's next stage of growth" reinforces materiality. The confidence is moderate (0.75) because the unaudited nature and explicit caveats about audit adjustments and revenue-recognition differences create some ambiguity about whether this rises to the level of a formal earnings release versus an operational announcement.
View raw filing on EDGAR →
8-K
M&A activity
confidence 99%
filed 2026-06-22
Item 1.01
Arcosa entered into an Agreement and Plan of Merger with CRH Americas on June 21, 2026, whereby Arcosa will be acquired for $150 per share in an all-cash transaction valued at approximately $8.5 billion. The transaction represents a change of control and is subject to customary closing conditions including stockholder approval and regulatory clearances, with an expected closing in Q1 2027.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-06-22
Item 5.02
Jeffrey Horowitz, Chief Compliance Officer, gave notice of retirement effective June 19, 2026. The filing explicitly states his departure was not due to disagreement with the Company. This is a straightforward executive departure of a named officer in a compliance-critical role, material to investor assessment of the registrant's governance and risk management structure.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-22
Item 3.02
Monroe Capital issued 1,222,087 shares of common stock at $9.77 per share for aggregate proceeds of $11.9 million pursuant to subscription agreements, with the sale exempt from registration under Section 4(a)(2) and Regulation D/S.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 98%
filed 2026-06-22
Item 8.01
The board declared a dividend distribution of $0.068 per share to stockholders of record as of June 23, 2026, payable on or about June 25, 2026.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-06-22
Item 2.02
HawkEye 360 issued a press release on June 22, 2026 announcing financial results for Q1 2026, disclosing record revenue of $49.8 million (up 116.5% YoY), a net loss of $(9.0) million, record adjusted EBITDA of $7.4 million, and a backlog of $285.0 million. The press release is furnished as Exhibit 99.1 under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings releases. This is a material disclosure affecting investor assessment of the registrant's financial performance and growth trajectory.
View raw filing on EDGAR →
8-K
Legal Other
confidence 85%
filed 2026-06-22
Item 7.01
The disclosure reports closure of a DOJ Antitrust Division grand jury investigation into health insurance practices, with the Company cleared of criminal investigation, but simultaneously reveals an ongoing civil investigative demand from the same division. This is a material legal/regulatory event involving government investigation that does not fit a specific named category (not litigation, not a settlement, not a covenant breach). The dual nature—closure of criminal inquiry but continuation of civil investigation—represents a significant regulatory development affecting the Company's legal exposure and business operations in healthcare.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-22
Item 5.07
This Item 5.07 disclosure reports the results of Butterfly Network's 2026 Annual Meeting of Stockholders held on June 18, 2026, with detailed voting tallies for three proposals: (1) election of seven directors, (2) ratification of Deloitte & Touche LLP as independent auditor, and (3) advisory vote on named executive officer compensation. The filing explicitly states the vote counts for each proposal, which is the core content of Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-22
Item 5.07
This is a clear Item 5.07 disclosure of shareholder vote results from the Company's June 18, 2026 annual meeting of stockholders. The filing reports voting outcomes on three proposals: election of two Class II directors (Neil Glat and Richard Shapiro), advisory approval of named executive officer compensation, and ratification of PricewaterhouseCoopers LLP as independent auditor. All proposals passed. This is material as it reflects shareholder governance decisions and auditor ratification.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-22
Item 3.02
Blue Owl Credit Income Corp. completed an unregistered private placement sale of 527,106 shares of Class I common stock for approximately $4.8 million, exempt under Section 4(a)(2) and Regulation S, to feeder vehicles created to hold the Company's Class I shares.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 92%
filed 2026-06-22
Item 8.01
The board declared monthly distributions to shareholders across three share classes (Class S, D, and I) on May 5, 2026, with specific gross and net distribution amounts per share payable by July 31 and August 31, 2026.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-22
Item 5.02
The Board elected Barry E. Greene as a Class I director on June 22, 2026. The disclosure centers on the appointment of a new director to the Board, including his compensation package (option grant of 57,463 shares at $20.87 and annual cash compensation of $45,000). This is a clear director appointment under Item 5.02, which is material to investors as it affects Board composition and governance.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 94%
filed 2026-06-22
Item 1.01
BuzzFeed entered into two share purchase agreements on June 17–18, 2026, selling 4,216,999 shares of Class A common stock (including 2,173,155 newly issued shares) at $1.44 per share for approximately $5.8 million in aggregate proceeds, pursuant to Section 4(a)(2) exemption from Securities Act registration. The transaction materially dilutes existing shareholders and raises capital at a modest valuation.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-22
Item 5.02
TaskUs appointed Rishabh Khemka as Chief Financial Officer effective June 19, 2026, succeeding interim CFO Trent Thrash who transitions to SVP of Corporate Development, Investor Relations and Treasury. The appointment includes detailed compensation arrangements including base salary, bonus, sign-on bonus, and equity grants.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 75%
filed 2026-06-22
Item 1.01
Sable Offshore amended its Senior Secured Term Loan Agreement with Exxon, extending the maturity date to July 24, 2026, suspending the $25 million minimum liquidity covenant, and waiving P&A Financial Security obligations, while agreeing to pay a $30 million amendment fee. The company also announced plans to enter into a new $775 million Senior Secured Term Loan to refinance the existing facility, representing material debt refinancing activity.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 92%
filed 2026-06-22
EX-99.2
SOPHiA GENETICS held its 2026 Annual General Meeting of shareholders, approving all proposals including the election of Dr. Jurgi Camblong as Executive Chairman (99.79% approval) and Ross Muken as a new Board member and incoming CEO effective July 1, 2026 (99.88% approval), reflecting a significant leadership transition and governance restructuring.
View raw filing on EDGAR →
8-K
M&A activity
confidence 97%
filed 2026-06-22
Item 3.02
Nextpower entered into a definitive Share Purchase Agreement to acquire Zimmermann PV-Steel Group for total consideration of up to €330 million (approximately $378 million), consisting of cash, stock, and contingent consideration. The acquisition materially expands Nextpower's product portfolio across four new product lines and geographic footprint into 15 additional countries, with the target expected to contribute approximately €300 million in annual revenue and €45 million in adjusted EBITDA on a run-rate basis, with expected close in H2 FY2027.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-22
Item 5.07
This Item 5.07 filing discloses the results of Blend Labs' June 17, 2026 annual meeting of stockholders, including voting outcomes for the election of seven directors and ratification of PricewaterhouseCoopers LLP as independent auditor. The filing presents tabulated vote counts (For, Against, Withheld, Broker Non-Votes) for each proposal, confirming all director nominees were elected and the auditor appointment was ratified. This is a classic shareholder_vote_results disclosure.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 92%
filed 2026-06-22
Item 8.01
Core & Main commenced a proposed amendment to its Term Loan Credit Agreement to enter into a new $800 million senior term loan, with proceeds intended to refinance $1,230 million of existing borrowings and for general corporate purposes. This constitutes creation of a new direct financial obligation through debt issuance, which is material to investors assessing the registrant's capital structure and leverage profile.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-22
Item 3.02
Barings Private Credit Corp completed an unregistered private placement of 585,012.268 shares of common stock for approximately $11.7 million pursuant to subscription agreements with investors, exempt under Section 4(a)(2) and Regulation D/S.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-06-22
Item 7.01
The Board declared a regular monthly distribution of $0.167 per share payable to stockholders of Barings Private Credit Corp.
View raw filing on EDGAR →
8-K
Operational Other
confidence 65%
filed 2026-06-22
Item 8.01
The Company reported its net asset value per share of $20.03 as of May 31, 2026, and provided a status update on its ongoing private offering of Common Stock, noting cumulative issuances of 145.76 million shares and total consideration received of $3.0 billion toward a $4.5 billion target.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-22
Item 3.02
Blue Owl Technology Income Corp. completed an unregistered private placement of 430,280 shares of Class I common stock for approximately $4.2 million, exempt under Section 4(a)(2) and Regulation S, diluting existing shareholders and raising capital.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 92%
filed 2026-06-22
Item 8.01
The board declared monthly distributions to shareholders across Class S, D, and I shares with specified gross and net distribution amounts payable in July and August 2026.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-22
Item 5.02
The filing discloses the appointment of Axel André as Chief Financial Officer of TPG Inc., effective July 27, 2026, with detailed compensation terms including a $500,000 base salary, $3.5M expected 2026 incentive allocation, $15M long-term equity award, and $4M platform-level allocation. While the filing also mentions Jack Weingart's transition from CFO to CEO of Global Wealth Solutions, the principal disclosed action centers on André's appointment to the CFO role, making this an executive appointment event.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-22
Item 5.01
Inderjit Mangat acquired 1,500,000 shares (57.47% of outstanding common stock) from Wang Hui for $300,000, effective June 17, 2026, resulting in a change of control of IMA Tech. The prior sole director/officer resigned and the new controlling shareholder was appointed as sole director/officer, confirming the control shift.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-06-22
Item 1.01
NorthWestern Energy Public Service Corporation issued $150 million principal amount of South Dakota First Mortgage Bonds on June 15, 2026, with a 5.51% interest rate and 10-year maturity, secured by first mortgage lien.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 85%
filed 2026-06-22
Item 2.03
The company entered into a Fifth Amendment to its existing Credit Agreement dated September 25, 2024, which materially modifies the terms of the credit facility by relaxing restrictions on certain restricted payments and altering covenant requirements.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-06-22
Item 8.01
The filing's primary disclosure under Item 8.01 is the Board of Trustees' declaration of a dividend distribution of $0.20 per Class I Share, payable in cash or reinvested through the Fund's distribution reinvestment plan. While the section also includes portfolio and NAV updates, the opening and substantive focus is on the dividend declaration, which is a material distribution event to shareholders.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This is a clear disclosure of shareholder voting results from the June 16, 2026 Annual Meeting of Shareholders under Item 5.07. The filing reports detailed vote tallies for four proposals: election of 7 directors, ratification of Grant Thornton LLP as auditor, Say-On-Pay advisory vote, and approval of the amended Omnibus Incentive Plan. All proposals passed with strong majorities, making this a material disclosure of shareholder actions that affects the composition of the board and governance structure.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-18
Item 8.01
The filing discloses shareholder approval of a merger agreement between Independent Bank Corporation and HCB Financial Corp., with anticipated closing on July 1, 2026. This represents a material acquisition/change of control event under Item 8.01, as the merger has cleared shareholder approval and is moving toward completion—a significant corporate transaction that would materially affect the registrant's business and financial position.
View raw filing on EDGAR →
8-K
Exec departure
confidence 92%
filed 2026-06-18
Item 5.02
Dave Denton, Chief Financial Officer, is stepping down from his position effective August 15, 2026, to pursue a professional opportunity outside the pharmaceutical industry. While the filing also discloses the interim appointment of Cecile Guegan as Interim CFO, the principal disclosed action centers on Denton's departure—a material executive departure at the C-suite level. The CFO role is critical to investor assessment of financial stewardship and strategy execution.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-06-18
Item 5.02
The disclosure centers on a Third Amended and Restated Employment Agreement with John H. Tyson, the Chairman, detailing comprehensive compensatory arrangements including a $3.5M annual base salary, 300% target annual incentive, $6M long-term incentive grants, a $40M one-time cash payment, aircraft use, personal security services, and severance provisions. This is a material executive compensation arrangement requiring 8-K disclosure under Item 5.02(e).
View raw filing on EDGAR →
8-K
Exec departure
confidence 92%
filed 2026-06-18
Item 5.02
John W. Rogers, Jr., a director since 2018, is retiring from the Board of Directors effective at the 2026 Annual Meeting and will not stand for re-election. Although he will transition to a strategic advisor role, his departure from the Board represents a material change in the company's governance structure.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-06-18
Item 1.01
Brady Corporation entered into a $1.0 billion credit agreement on June 12, 2026, to finance its pending acquisition of Honeywell International Inc.'s Productivity Solutions and Services business. The financing facility is directly tied to the PSS acquisition closing and will materially affect the registrant's capital structure and financial obligations.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-18
Item 7.01
Camden National Corporation furnished an investor presentation under Item 7.01 (Regulation FD Disclosure) for use in upcoming investor meetings. The presentation contains comprehensive financial and operational information including balance sheet metrics ($7.0B assets, $5.6B deposits), strategic objectives, capital management, and forward-looking statements. While Item 7.01 disclosures are typically routine, this presentation is material to investors as it provides substantive updates on the company's financial position, strategic initiatives, and performance metrics that would affect investment decisions, particularly given the company's recent Northway acquisition and ongoing capital management strategy.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
Autodesk held its 2026 Annual Meeting of stockholders, at which eleven directors were elected to the Board and stockholders voted on four proposals: ratification of the independent auditor, an advisory vote on executive compensation, approval of a certificate amendment relating to officer exculpation, and a proposal regarding stockholder special meeting rights. The detailed vote results for each director and proposal are disclosed.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-18
Item 5.02
The filing discloses the election of David R. Heppner as a new director of The Andersons, Inc., effective June 18, 2026. The principal action is a person taking a board role. While the Item 5.02 section also mentions compensation arrangements, the core disclosure centers on the appointment itself, making exec_appointment the most salient classification. Board appointments are material to investors as they affect governance and strategic direction.
View raw filing on EDGAR →